Skip to main navigation
Zosano Pharma Logo links to zosanopharma.com
Home
  • About
    • Leadership
    • Board of Directors
    • Contact
  • Technology
    • Publications
  • Investors

    Investor Relations

    • Investors
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Management
      • Board of Directors
      • Committee Composition
    • Financials & Filings
      • SEC Filings
      • Annual Reports and Proxies
    • Stock Information
      • Historic Stock Lookup
    • Investor FAQs
    • Clinical Trial Data
    • Contact Us
  • Contact

Investor Relations

  • Investors
  • Press Releases
  • Events & Presentations
  • Corporate Governance
    • Management
    • Board of Directors
    • Committee Composition
  • Financials & Filings
    • SEC Filings
    • Annual Reports and Proxies
  • Stock Information
    • Historic Stock Lookup
  • Investor FAQs
  • Clinical Trial Data
  • Contact Us

Shareholder Tools

  • Printed Materials
  • Email Alerts
  • Download
  • RSS Feeds
  • Print
  • Share
  • Facebook
  • LinkedIn
  • Twitter
  • RSS

SEC Filing Details

Document Details

Form
4
Filing Date
Jun 14, 2021
Document Date
Jun 10, 2021
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Zosano Pharma Corporation

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS
  • About

    • Leadership
    • Board of Directors
    • Contact
  • Technology

    • Publications
  • Investor Relations

    • Investors
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Management
      • Board of Directors
      • Committee Composition
    • Financials & Filings
      • SEC Filings
      • Annual Reports and Proxies
    • Stock Information
      • Historic Stock Lookup
    • Investor FAQs
    • Clinical Trial Data
    • Contact Us
  • Contact

  • Terms of Use
© 2022 Zosano Pharma CorporationAll rights reserved
  • Terms of Use
Website Design: Hane Chow, Inc.